Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 15,029 | 12,977 | 13,186 | 12,932 | 16,696 |
| Operating Income | -15,029 | -12,977 | -13,186 | -12,932 | -16,696 |
| Other Income | 7,185 | 1,386 | 843 | 724 | 240 |
| Pre-tax Income | -7,843 | -11,590 | -12,343 | -12,208 | -16,457 |
| Income Tax | 44 | 29 | 10 | 11 | 26 |
| Net Income Continuous | -7,887 | -11,619 | -12,353 | -12,219 | -16,483 |
| Minority Interests | -451 | -2,193 | -2,214 | -3,214 | -9,271 |
| Net Income | $-7,437 | $-9,426 | $-10,139 | $-9,005 | $-7,197 |
| EPS Basic Total Ops | -0.09 | -0.18 | -0.23 | -0.23 | 2.08 |
| EPS Basic Continuous Ops | -0.08 | -0.22 | -0.28 | -0.31 | 1.86 |
| EPS Diluted Total Ops | -0.09 | -0.18 | -0.23 | -0.23 | 2.08 |
| EPS Diluted Continuous Ops | -0.08 | -0.22 | -0.28 | -0.31 | 1.86 |
| EBITDA(a) | $-14,669 | $-12,974 | $-13,183 | $-12,928 | $-16,541 |